Russell Investments Group’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $24.6K | Sell |
7,952
-914
| -10% | -$2.82K | ﹤0.01% | 3147 |
|
|
2025
Q1 | $30.9K | Buy |
8,866
+6,350
| +252% | +$22.2K | ﹤0.01% | 3012 |
|
|
2024
Q4 | $8.23K | Sell |
2,516
-2,267
| -47% | -$7.41K | ﹤0.01% | 3180 |
|
|
2024
Q3 | $18.4K | Buy |
4,783
+1,319
| +38% | +$5.08K | ﹤0.01% | 2977 |
|
|
2024
Q2 | $10.7K | Buy |
3,464
+318
| +10% | +$983 | ﹤0.01% | 3059 |
|
|
2024
Q1 | $8.12K | Buy |
3,146
+883
| +39% | +$2.28K | ﹤0.01% | 2873 |
|
|
2023
Q4 | $5.66K | Sell |
2,263
-1,840
| -45% | -$4.6K | ﹤0.01% | 2895 |
|
|
2023
Q3 | $8.33K | Buy |
4,103
+3,946
| +2,513% | +$8.01K | ﹤0.01% | 3051 |
|
|
2023
Q2 | $361 | Sell |
157
-1,187
| -88% | -$2.73K | ﹤0.01% | 3380 |
|
|
2023
Q1 | $4.07K | Buy |
+1,344
| New | +$4.07K | ﹤0.01% | 2960 |
|
|
2022
Q2 | – | Sell |
-4,120
| Closed | -$12K | – | 2872 |
|
|
2022
Q1 | $12K | Hold |
4,120
| – | – | ﹤0.01% | 2702 |
|
|
2021
Q4 | $16K | Sell |
4,120
-4,323
| -51% | -$16.8K | ﹤0.01% | 2961 |
|
|
2021
Q3 | $36K | Sell |
8,443
-4,614
| -35% | -$19.7K | ﹤0.01% | 2964 |
|
|
2021
Q2 | $39K | Buy |
+13,057
| New | +$39K | ﹤0.01% | 3149 |
|
|
2020
Q3 | – | Sell |
-43,100
| Closed | -$78K | – | 3172 |
|
|
2020
Q2 | $78K | Buy |
+43,100
| New | +$78K | ﹤0.01% | 2929 |
|